Canada - English - Health Canada

langford - streptomycin (streptomycin sulfate); neomycin (neomycin sulfate); selenium (selenium sulfide); vitamin a; vitamin d; vitamin e; vitamin k1 - tablet - 60mg; 60mg; .15mg; 10000unit; 1000unit; 10unit; 10mg - streptomycin (streptomycin sulfate) 60mg; neomycin (neomycin sulfate) 60mg; selenium (selenium sulfide) .15mg; vitamin a 10000unit; vitamin d 1000unit; vitamin e 10unit; vitamin k1 10mg - cattle

United States - English - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - streptomycin sulfate (unii: cw25ikj202) (streptomycin - unii:y45qso73ob) - streptomycin 1 g - streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: - mycobacterium tuberculosis: the advisory council for the elimination of tuberculosis, the american thoracic society, and the center for disease control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (inh), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of inh or rifampin resistance is very low. the need for a fourth drug should be reassessed when the results of susceptibility testing are known. in the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. if community rates of inh resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be co

United States - English - NLM (National Library of Medicine)

hi-tech pharmacal co. inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin sulfate 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets and other antibacterial drugs, neomycin sulfate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidimiology and susceptibility patterns may contribute to the empiric selection of therapy. suppression of intestinal bacteria : neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, eg, preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section) . hepatic coma (portal-systemic encephalopathy) : neomycin sulfate has been shown to be effective adjunctive therapy in hepatic com

United States - English - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin sulfate 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets, usp and other antibacterial drugs, neomycin sulfate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. neomycin sulfate tablets, usp are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g. preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section) . neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal

United States - English - NLM (National Library of Medicine)

lannett company, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets and other antibacterial drugs, neomycin sulfate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. suppression of intestinal bacteria neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g., preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration ). hepatic coma (portal-systemic encephalopathy) neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction o

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets, usp and other antibacterial drugs, neomycin sulfate tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, eg, preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration ). neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. the subsequent r

United States - English - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin 350 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets usp and other antibacterial drugs, neomycin sulfate tablets usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. suppression of intestinal bacteria:   neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel, e.g., preoperative preparation of the bowel. it is given concomitantly with erythromycin enteric-coated base (see dosage and administration section). hepatic coma (portal-systemic encephalopathy):   neomycin sulfate has been shown to be effective adjunctive therapy in hepati

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin sulfate 500 mg

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - neomycin sulfate 500 mg

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o box 16633-00620 nairobi, kenya - streptomycin sulphate - powder for suspension for injection - streptomycin (as sulphate) bp 1g/vial - antibacterials for systemic use: aminoglycosides